RecruitingNot ApplicableNCT06466330

Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial


Sponsor

Societe Francaise de Rhumatologie

Enrollment

112 participants

Start Date

Mar 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical investigation is to evaluate the effectiveness on pain of arterial occlusion (embolization) of neovessels by microparticle in a double-blind sham controlled randomised trial in patients with persistent pain on a total knee prosthesis (TKP), inserted for gonarthrosis, despite well-conducted medical treatment. The study patient population will consist of up to 112 subjects with knee pain for at least 3 months that is resistant to conservative treatment measures. Subjects will be treated with knee embolisation or saline in the sham arm. The efficacy of embolization will be judged on the basis of the following criteria: improvement in pain, mobility, use of pain medication, adverse effects of embolization and duration of improvement. After verification of eligibility criteria, patients with painful total knee prosthesis will be randomized to either the embolization group or the control group. Embolization will be performed using microparticles (Embozene® Microspheres 100 microns from Varian), for the treatment group. For the "sham " group, only diagnostic arteriography will be performed without injection of microparticles. Subjects will be followed up at 1, 3, 6 and 12 months.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called embolization, a medical device called microparticles, and others for people with knee pain chronic and knee pain swelling. The study is currently recruiting participants at 11 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEmicroparticles

inert microparticles

PROCEDUREembolization

Injection of inert microparticles in neovessels using a microcatheter

PROCEDUREsham embolization

injection of saline solution


Locations(11)

Centre Hospitalier Henri Mondor

Créteil, France

Centre Hospitalier Dijon

Dijon, France

Centre Hospitalier Universitaire de Grenoble

Grenoble, France

Centre Hospitalier Saint-Philibert

Lomme, France

Hôpital Saint Philibert

Lomme, France

CHU Marseille

Marseille, France

Centre Hospitalier Universitaire de Nice

Nice, France

Centre Hospitalier de Nîmes

Nîmes, France

Hôpital Lariboisière

Paris, France

Hôpital Saint-Antoine

Paris, France

Hospices Civils de Strasbourg

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06466330


Related Trials